Perceptive Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-140,726
Closed -$939K 104
2025
Q1
$939K Sell
140,726
-237,858
-63% -$2.35M 0.03% 79
2024
Q4
$4.76M Sell
378,584
-553,267
-59% -$8.33M 0.13% 72
2024
Q3
$17.2M Sell
931,851
-314,746
-25% -$6.45M 0.37% 60
2024
Q2
$26.8M Sell
1,246,597
-554,471
-31% -$12.7M 0.65% 47
2024
Q1
$48.5M Buy
1,801,068
+93,670
+5% +$2.66M 0.86% 40
2023
Q4
$51.2M Buy
1,707,398
+189,931
+13% +$4.19M 1.14% 27
2023
Q3
$31.1M Buy
1,517,467
+349,104
+30% +$6.35M 1.05% 31
2023
Q2
$23.2M Buy
1,168,363
+300,631
+35% +$6.07M 0.67% 45
2023
Q1
$14.9M Sell
867,732
-210,472
-20% -$4.12M 0.44% 52
2022
Q4
$21.1M Buy
1,078,204
+578,204
+116% +$10.6M 0.61% 41
2022
Q3
$7.98M Sell
500,000
-666,883
-57% -$10.4M 0.23% 70
2022
Q2
$16.1M Sell
1,166,883
-511,207
-30% -$6.09M 0.5% 45
2022
Q1
$26.6M Sell
1,678,090
-281,035
-14% -$4.86M 0.53% 46
2021
Q4
$42.8M Sell
1,959,125
-351,136
-15% -$9.58M 0.66% 39
2021
Q3
$69.1M Sell
2,310,261
-441,342
-16% -$16.1M 1.01% 27
2021
Q2
$122M Sell
2,751,603
-116,168
-4% -$5.05M 1.58% 16
2021
Q1
$127M Sell
2,867,771
-529,096
-16% -$29.1M 1.69% 19
2020
Q4
$186M Buy
3,396,867
+1,207,857
+55% +$44M 2.01% 11
2020
Q3
$50M Hold
2,189,010
0.74% 36
2020
Q2
$45.8M Hold
2,189,010
0.74% 34
2020
Q1
$30.5M Sell
2,189,010
-50,231
-2% -$995K 0.8% 31
2019
Q4
$51M Buy
2,239,241
+261,829
+13% +$4.37M 1.02% 22
2019
Q3
$23M Hold
1,977,412
0.62% 39
2019
Q2
$29.7M Buy
1,977,412
+1,519,239
+332% +$26.5M 0.68% 38
2019
Q1
$8.04M Buy
458,173
+218,000
+91% +$3.44M 0.23% 65
2018
Q4
$3.5M Buy
+240,173
New +$3.99M 0.13% 68

Other funds holding RCKT